# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001628280-21-015831
Filing Date
2021-08-05
Accepted
2021-08-05 16:01:26
Documents
15
Period of Report
2021-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | crdf-20210805.htm iXBRL | 8-K | 39505
2 | EX-99.1 | crdf8521-q22021pr.htm | EX-99.1 | 134261
6 |  | cardiff_logoxrgbxtm.jpg | GRAPHIC | 176318
7 |  | crdf-20210805_g1.jpg | GRAPHIC | 176318
| Complete submission text file | 0001628280-21-015831.txt |  | 987170

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | crdf-20210805.xsd | EX-101.SCH | 1935
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | crdf-20210805_lab.xml | EX-101.LAB | 23007
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | crdf-20210805_pre.xml | EX-101.PRE | 12131
8 | EXTRACTED XBRL INSTANCE DOCUMENT | crdf-20210805_htm.xml | XML | 10034

Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 211148042
SIC: 2836 Biological Products, (No Diagnostic Substances)